Jason Miele
Analyst · MST Marquee. Please go ahead
Thank you, Jack. I will start on Slide 10 with our group results for the first quarter of fiscal year 2021. In the first quarter, we were able to deliver adjusted EBIT and adjusted NOPAT in line with the prior year. This was driven by the continued execution and acceleration of our strategy and our focus on controlling what we can control. In all three regions we saw improved top line results, each successive month of the quarter, and we enter the second quarter with good momentum in all three regions. The adjusted EBIT result of flat for the quarter was driven by the strong positive result in North America where we increased adjusted EBIT by $17.4 million, which was offset by decreases in Asia Pacific and Europe, as well as a significant headwind in stock compensation expenses which increased $7.1 million due to appreciation of the stock price during the first quarter. From the adjusted NOPAT perspective, our result of $89.3 million was in line with prior year, driven by the slight improvement in adjusted EBIT and lower interest expense offset by a higher adjusted effective tax rate. Most notably, our concerted efforts to improve the management and discipline with respect to our working capital and our continued strong sales results driven by customer integration resulted in increase in operating cash flow of $49 million, a 35% increase versus the prior corresponding period. Moving on Page 11; I'll now go through each region in more detail, starting with North America. In North America, we saw outstanding results for the quarter. First, I'll briefly go through the market activity we observed during the quarter. Obviously, with the onset of the pandemic in March, the first quarter experienced uncertainty and volatile activity across the various segments and geographies we participated. In general, new construction, including single family and multifamily was the strongest segment throughout the quarter. While we saw a dip early in the quarter, it was not as deep as the dip we saw in repair and remodel activity, and the rebound in activity was faster and steeper. In the repair and remodel market for our exterior siding, we observed a significant decrease in activity early in the quarter but saw higher levels of activity each successive month of the quarter. Similarly, in the interiors market, we saw significant decreases in activity early in the quarter as consumers were hesitant to allow contractors inside their home. While we saw this activity increase late in the quarter, and I've seen that persist into July. Moving on to our top line results as we navigated that volatile and uncertain market. Volume and net sales were flat versus prior corresponding period, with exteriors up 1%, and interiors down 11%. In both, exteriors and interiors, we saw improvement in our sales volumes in each successive month of the quarter. Our exteriors volume increased 1% versus the prior corresponding period driven by continued share gain as our team continues to be customer-focused. We have seen this momentum continue into the second quarter, and Jack will provide specific second quarter exteriors volume guidance a bit later in the presentation. In interiors, while volumes decreased in Q1 by 11% versus the prior corresponding period, we did see improvements each successive month of the quarter, and that trend continued into July with our interiors volume comping slightly positive versus July fiscal year '20. While our top line result was flat, we were able to grow adjusted EBIT by $17.4 million or 15%, this was driven by strong execution by our North America team, controlling what we can control and executing and accelerating our strategy through the pandemic. Specifically, adjusted EBIT improved due to; one, continued lean savings, lower freight costs, lower coke [ph] costs, and lower SG&A. These improvements more than offset higher fixed cost absorption due to lower production volumes, early in the quarter, and other incremental expenses associated with COVID. In Q1, the North America team delivered exceptional results with continued growth above market and strong returns, including an adjusted EBIT margin of 29%. Adjusted EBIT increased 15% while adjusted EBIT margin increased by 390 basis points. Turning to Page 12, we'll talk about the Asia Pacific results. Similar to North America, Asia Pacific also had to navigate volatile and uncertain markets during Q1, and in some regards, more uncertain and more volatile. Our Asia Pacific results in Q1 were significantly impacted by the government imposed COVID-19 lockdowns in The Philippines and New Zealand during the first quarter. Despite two of its three markets facing these lockdowns, Asia Pacific was able to deliver an improvement in adjusted EBIT margin from last year, and shift back to the top end of a long-term range at 24.4% adjusted EBIT margin. This result was led by a very strong result from our Australia business as they continue to drive growth above market and strong returns. Australia increased volume by 1% versus prior corresponding period while delivering an adjusted EBIT margin comparable to that of our North American business. Also, you'll remember that on May 5, 2020 we announced the closure of our James Hardie Systems business, as well as the closure of our Penrose, New Zealand manufacturing facility. Both closures are on-track and we are seeing positive impacts to our EBIT margin related to both actions as we continue to shift the remaining New Zealand production to a more efficient Australian manufacturing network. We would expect the impact to continue and to improve. As the government lockdowns have been eased or lifted in New Zealand and The Philippines, we have begun to experience some positive momentum toward the end of the quarter, and continue to see that momentum into the second quarter. Let's now move on to Page 13 for our European results. I'll pause for a moment to let the slide catch up. Slide 13, please. Europe is a segment that experienced the greatest impact of the COVID-19 pandemic as net sales decreased 12% in the first quarter, driven largely by government and post-shutdowns in two of our key markets, The United Kingdom and France. It is important to note that these are also key fiber cement markets for us. By product group, net sales of fiber cement decreased 19%, and net sales of fiber gypsum decreased 11%. As a smaller segment with a higher SG&A base as a percent of revenue, this type of top line reduction with a negative shift in mix and lower production can significantly impact margins quickly, and that is what happened in Q1 for our Europe segment. Adjusted EBIT margin of 2.9% was driven by unfavorable absorption of manufacturing costs on lower production volumes and unfavorable mix impacts driven by reduction in fiber cement as a percentage of the overall portfolio. Note, that the margin of our fiber cement products is significantly higher than that of our fiber gypsum products. While the Europe first quarter result is below our expectations, we have seen good momentum entering Q2 which ally [ph] revenue up double digits versus July FY '20, as markets in France and The United Kingdom started to open. Further as the year progresses, we will gain the benefits of the resource reallocations we announced in May. More importantly, our European management team is working closely with their colleagues in North America and Asia-Pac to drive a focus on high gross margin products and improving penetration in existing and new fiber cement markets. Moving to Page 14; we'll briefly cover off on the other segments. Starting on the left-hand side of the slide, you will see a significant increase in general corporate costs in the - versus the first quarter of prior corresponding period. In the first quarter stock compensation expenses increased $7.1 million, driven by share price accretion from March 31, 2020 to June 30, 2020. Our share price increased AUD9 during that period, resulting in a significant increase in stock compensation expense. On the right-hand side of the slide, you can see R&D expenditures were relatively flat year-on-year. The global innovation team remains focused on customer and market-driven innovation, as you heard Jack discuss in the strategy update. And we anticipate additional investment in innovation during FY '21 and into the future. Now, if we turn to Page 15, there is a summary of adjusted NOPAT. This is a new slide we have to summarize the adjusted EBIT results by segment, and then provide clarity straight through to adjusted NOPAT. First, I want to cover off on the last bullet on the slide. As we announced on May 19, we anticipated incurring approximately $10.5 million in severance costs associated with the restructuring actions we announced on May 5, and that we expected to exclude those costs from adjusted EBIT and adjusted NOPAT. We have done exactly that; we incurred a total of $11.1 million in severance costs, slightly above our $10.5 million estimate, and have included them as restructuring costs in our first quarter fiscal year '21 income statement. Severance is the only item we have included as restructuring costs while there are other incremental costs associated with the COVID pandemic such as increased hygiene, increased cleaning costs, and increased PP&E costs amongst others. We did not feel it was relevant to exclude those items from adjusted EBIT and adjusted NOPAT as some of them or all of them may continue and may not be one-off in nature. So again, for clarity, the $11.1 million in restructuring costs solely consists of severance, and we have excluded that amount from adjusted EBIT and adjusted NOPAT. Shifting back to the results; while adjusted NOPAT is relatively flat versus the prior corresponding period, we are very pleased with the quality of that result. We delivered flat adjusted NOPAT despite the uncertain and volatile markets of the pandemic, including some of our markets and plants being shut down due to government restrictions, and despite the headwinds of higher stock compensation expense, and a higher adjusted effective tax rate. The underlying operating units; North America, Asia Pacific, Europe and research and development combined to deliver $9.2 million in adjusted EBIT growth led by the outstanding North American result that delivered an increase of $17.4 million adjusted EBIT to more than offset the decreases in Asia Pacific and Europe. We move now to Slide 16; we'll discuss cash flows and capital expenditures. Starting on the left-hand side of the slide, we'll talk about cash flows. As Jack and I have both mentioned earlier in our presentation, operating cash flows were up 35% for the first quarter versus prior corresponding period, driven largely by increased engagement with our customers to drive sales growth and share gain and integration of our entire supply chain to reduce inventory, while also improving service. Since March 31, 2020, we have seen a total reduction in working capital of $79.3 million. Should be noted, we also received a $23.3 million tax refund in the first quarter under the provisions of the US CARES Act, which was put in place by the U.S. federal government post-COVID. For the quarter lower cash was used in investing activities, largely driven by lower capital expenditures. And lastly, we saw higher cash used in financing activities as we made higher repayments of debt balances with the significant increases in our operating cash flows. Now shifting to the right-hand side of the slide where you'll see a summary of capital expenditures. For the first quarter CapEx spend was $27.1 million, down $36 million versus the prior corresponding quarter as we had lower capacity expansion activities year-over-year. In May, we noted we did not expect to commission our Prattville, Alabama facility, nor our Carole Park, Australia, Brownfield expansion until FY '22. Due to our strong customer integration and market share game, in both North America and Asia Pacific, we now anticipate to commission both facilities in the fourth quarter of this fiscal year FY '21. We now expect our full year FY '21 capital expenditures to be approximately US$110 as we intend to convince [ph] both the aforementioned facilities in the fourth quarter, and also increase maintenance CapEx due to production. Now, let's turn Page 17 where we'll briefly discuss liquidity. We've consistently provided this slide for many years now. There is no change in our debt profile of the three sets of notes in place along with the revolving credit facility. As Jack mentioned earlier in the presentation, we continue to improve our liquidity position and our leverage position. We ended the quarter with $693.1 million in liquidity, an improvement of $183.3 million since March 31. We also improved leverage to 1.65 times, an improvement from 1.9 times at March 31. Overall, we remain well positioned with a healthy liquidity position and significant financial flexibility. Now, let's move to Page 18. And I will close my section with an update on capital management and allocation. We are committed to maintaining our financial flexibility throughout the pandemic, and we believe this short-term capital management strategy is aligned with that commitment. Through the end of fiscal year 2021, we expect the following capital management focus; maintain flexibility through the market volatility and uncertainty of the global pandemic, invest strategically in capacity expansion to support organic growth, invest in market-led innovation to position James Hardie for continued organic growth in the future, have a continued focus on reducing our leverage ratio, maintain flexibility to reduce gross debt, and the continued suspension of ordinary dividend payments through the end of FY '21. We expect this pragmatic approach to capital management will not only allow us to continue to thrive through the pandemic, but will also allow us to exit the pandemic with significant financial flexibility to support our growth agenda. I will now hand the call back over to Jack for a summary and an update on guidance.